DATE CORRECTION - Testosterone (Reandron) Injection

This is to correct the dates sent out on Friday. Gonadron brand will be listed 1 July 2026

Brand change:

We are writing to inform you of a brand change for testosterone undecanoate inj 250 mg per ml, (Reandron)

Key Dates:

• The Gonadron brand of testosterone undecanoate inj 250 mg per ml is to be listed (funded) from 1 July 2026 on the Community Schedule and in Health NZ hospitals.

• Testosterone undecanoate inj 250 mg per ml (Reandron) brand will be delisted (no longer funded) 1 December 2026.

• The active ingredients and excipients are the same as the Reandron brand.

• For more information about this change see Testosterone injection on Pharmac website

Questions: 

If you have any queries, please contact us at enquiry@pharmac.govt.nz

Please share this information:

Please share this information with your colleagues and within your networks.

ou.

Ngā mihi,

Anna I Senior Advisor Implementation

Pharmac | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington

P: 0800 660 050 | www.pharmac.govt.nz